Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Stewart

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|April 24, 2024
Increased Virtual Visits to Physicians During the COVID-19 Pandemic and Estimated Impact on Physician Compensation: The Case of Lung and Colorectal Cancers, Chronic Obstructive Pulmonary Diseases, and Heart Failure in Alberta, CanadaNguyen Xuan Thanh, Arianna Waye, Douglas Stewart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2012
Reovirus as a viable therapeutic option for the treatment of multiple myelomaChandini M Thirukkumaran, Zhong Qiao Shi, Joanne Luider, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 31, 2012
Fludarabine, busulfan, antithymocyte globulin, and total body irradiation for pretransplantation conditioning in acute lymphoblastic leukemia: excellent outcomes in all but older patients with comorbiditiesAndrew Daly, Mary L Savoie, Michelle Geddes, et al.
Ejhaem|January 27, 2025
Characteristics of relapsed/refractory diffuse large B-cell lymphoma patients with durable responses to maveropepimut-S, pembrolizumab, and cyclophosphamide: Long-term follow-up from the SPiReL trialArjun Pandey, Kim Roos, Yidi Jiang, et al.
Clinical Transplantation|May 24, 2022
Toward optimization of cyclosporine concentration target to prevent acute graft-versus-host disease following myeloablative allogeneic stem cell transplantAlex Chi Fung Kwan, Nikki Blosser, Sunita Ghosh, et al.
Blood Advances|January 4, 2018
Zoster prophylaxis after allogeneic hematopoietic cell transplantation using acyclovir/valacyclovir followed by vaccinationKareem Jamani, Judy MacDonald, Martin Lavoie, et al.
European Journal of Haematology|May 9, 2023
PD-L1 expression predicts efficacy in the phase II SPiReL trial with MVP-S, pembrolizumab, and low-dose CPA in R/R DLBCLIrina Amitai, Kim Roos, Iran Rashedi, et al.
Leukemia & Lymphoma|September 27, 2024
Intensity of survivin expression linked to features of aggressive relapsed/refractory diffuse large B-cell lymphomaSila Usta, Alexandra Misura, Iran Rashedi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 25, 2008
High busulfan exposure is associated with worse outcomes in a daily i.v. busulfan and fludarabine allogeneic transplant regimenMichelle Geddes, S Bill Kangarloo, Farrukh Naveed, et al.
Cell Reports|September 23, 2016
Human iNKT Cells Promote Protective Inflammation by Inducing Oscillating Purinergic Signaling in Monocyte-Derived DCsXuequn Xu, Ginger M Pocock, Akshat Sharma, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|April 24, 2024
Increased Virtual Visits to Physicians During the COVID-19 Pandemic and Estimated Impact on Physician Compensation: The Case of Lung and Colorectal Cancers, Chronic Obstructive Pulmonary Diseases, and Heart Failure in Alberta, CanadaNguyen Xuan Thanh, Arianna Waye, Douglas Stewart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2012
Reovirus as a viable therapeutic option for the treatment of multiple myelomaChandini M Thirukkumaran, Zhong Qiao Shi, Joanne Luider, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 31, 2012
Fludarabine, busulfan, antithymocyte globulin, and total body irradiation for pretransplantation conditioning in acute lymphoblastic leukemia: excellent outcomes in all but older patients with comorbiditiesAndrew Daly, Mary L Savoie, Michelle Geddes, et al.
Ejhaem|January 27, 2025
Characteristics of relapsed/refractory diffuse large B-cell lymphoma patients with durable responses to maveropepimut-S, pembrolizumab, and cyclophosphamide: Long-term follow-up from the SPiReL trialArjun Pandey, Kim Roos, Yidi Jiang, et al.
Clinical Transplantation|May 24, 2022
Toward optimization of cyclosporine concentration target to prevent acute graft-versus-host disease following myeloablative allogeneic stem cell transplantAlex Chi Fung Kwan, Nikki Blosser, Sunita Ghosh, et al.
Blood Advances|January 4, 2018
Zoster prophylaxis after allogeneic hematopoietic cell transplantation using acyclovir/valacyclovir followed by vaccinationKareem Jamani, Judy MacDonald, Martin Lavoie, et al.
European Journal of Haematology|May 9, 2023
PD-L1 expression predicts efficacy in the phase II SPiReL trial with MVP-S, pembrolizumab, and low-dose CPA in R/R DLBCLIrina Amitai, Kim Roos, Iran Rashedi, et al.
Leukemia & Lymphoma|September 27, 2024
Intensity of survivin expression linked to features of aggressive relapsed/refractory diffuse large B-cell lymphomaSila Usta, Alexandra Misura, Iran Rashedi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 25, 2008
High busulfan exposure is associated with worse outcomes in a daily i.v. busulfan and fludarabine allogeneic transplant regimenMichelle Geddes, S Bill Kangarloo, Farrukh Naveed, et al.
Cell Reports|September 23, 2016
Human iNKT Cells Promote Protective Inflammation by Inducing Oscillating Purinergic Signaling in Monocyte-Derived DCsXuequn Xu, Ginger M Pocock, Akshat Sharma, et al.
Pageof 8